Inspire Medical Systems Files 8-K
Ticker: INSP · Form: 8-K · Filed: Nov 17, 2025 · CIK: 1609550
| Field | Detail |
|---|---|
| Company | Inspire Medical Systems, INC. (INSP) |
| Form Type | 8-K |
| Filed Date | Nov 17, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001, $90 million, $100 million, $3.00, $3.30 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, other-events
TL;DR
Inspire Medical Systems dropped an 8-K, something happened, details TBD.
AI Summary
Inspire Medical Systems, Inc. filed an 8-K on November 17, 2025, to report other events. The filing does not contain specific details about the nature of these events, dollar amounts, or new agreements.
Why It Matters
This filing indicates a material event has occurred for Inspire Medical Systems, Inc., requiring disclosure to investors, though the specifics are not yet detailed.
Risk Assessment
Risk Level: medium — The filing is an 8-K for 'Other Events,' which can range from minor administrative changes to significant undisclosed events, creating uncertainty.
Key Players & Entities
- Inspire Medical Systems, Inc. (company) — Registrant
- November 17, 2025 (date) — Date of report
FAQ
What specific 'Other Events' are being reported by Inspire Medical Systems, Inc. in this 8-K filing?
The provided text of the 8-K filing does not specify the nature of the 'Other Events' being reported.
When was this 8-K report filed by Inspire Medical Systems, Inc.?
The 8-K report was filed on November 17, 2025.
What is the exact name of the registrant as specified in its charter?
The exact name of the registrant is Inspire Medical Systems, Inc.
What is the Commission File Number for Inspire Medical Systems, Inc.?
The Commission File Number for Inspire Medical Systems, Inc. is 001-38468.
What is the principal executive office address for Inspire Medical Systems, Inc.?
The principal executive office address is 5500 Wayzata Blvd., Suite 1600, Golden Valley, Minnesota 55416.
Filing Stats: 549 words · 2 min read · ~2 pages · Grade level 10.1 · Accepted 2025-11-17 16:36:42
Key Financial Figures
- $0.001 — ange on which registered Common Stock, $0.001 par value per share INSP New York Stock
- $90 million — n an income tax benefit in the range of $90 million to $100 million for the year, which is
- $100 million — benefit in the range of $90 million to $100 million for the year, which is expected to incr
- $3.00 — ted earnings per share by approximately $3.00 to $3.30 for the same period. Forward
- $3.30 — ngs per share by approximately $3.00 to $3.30 for the same period. Forward-Looking
Filing Documents
- insp-20251117.htm (8-K) — 23KB
- 0001609550-25-000055.txt ( ) — 139KB
- insp-20251117.xsd (EX-101.SCH) — 2KB
- insp-20251117_lab.xml (EX-101.LAB) — 22KB
- insp-20251117_pre.xml (EX-101.PRE) — 13KB
- insp-20251117_htm.xml (XML) — 3KB
01. Other Events
Item 8.01. Other Events. On November 6, 2025, Inspire Medical Systems, Inc. ("Inspire" or the "Company") disclosed its expectation to release a significant portion of the valuation allowance on its U.S. deferred tax assets during the fourth quarter of fiscal 2025. The Company estimates that this release will result in an income tax benefit in the range of $90 million to $100 million for the year, which is expected to increase diluted earnings per share by approximately $3.00 to $3.30 for the same period.
Forward-Looking Statements
Forward-Looking Statements This Current Report on Form 8-K contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the Company's expectation to release a valuation allowance on its U.S. deferred tax assets and the anticipated impact on income tax expense and earnings per share. These forward-looking statements are based on current assumptions and involve risks and uncertainties that could cause actual results to differ materially. Factors that could affect these results are discussed in the Company's filings with the Securities and Exchange Commission. The Company undertakes no obligation to update these statements except as required by law. 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INSPIRE MEDICAL SYSTEMS, INC. Date: November 17, 2025 By: /s/ Bryan K. Phillips Bryan K. Phillips Sr. Vice President, General Counsel and Secretary 3